Stanford University
Showing 5,291-5,300 of 7,907 Results
-
Anil K. Panigrahi
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Associate Professor (By courtesy), PathologyBioAnil K. Panigrahi, MD, PhD, FASA is a Clinical Associate Professor in the Departments of Anesthesiology and, by courtesy, Pathology at Stanford University School of Medicine. Dual board-certified in Anesthesiology and Blood Banking/Transfusion Medicine, he maintains active clinical practice in both fields. He serves as Director of Patient Blood Management at Stanford Health Care, Chair of the Stanford Health Care Transfusion Committee, Medical Director of the Anesthesiology Perioperative Anemia Management Clinic, and Assistant Medical Director of the Stanford Health Care Transfusion Service. His academic and clinical leadership focuses on advancing perioperative blood management strategies to optimize outcomes in complex surgical patients.
A Phi Beta Kappa graduate of Duke University, Dr. Panigrahi received his M.D. and Ph.D. degrees from the University of Pennsylvania School of Medicine, where he was awarded the John G. Clark Prize for meritorious research. He completed residency training in Anesthesiology and fellowship in Blood Banking/Transfusion Medicine at Stanford University.
Dr. Panigrahi’s scholarly work spans immunology, transfusion safety, and patient blood management. He has authored numerous peer-reviewed publications, textbook chapters, including for Miller’s Anesthesia and the AABB Technical Manual, and national guidelines. He contributes nationally through service on multiple committees for the American Society of Anesthesiologists (ASA) and the Association for the Advancement of Blood and Biotherapies (AABB), and he is a frequent invited speaker at national and international meetings, including those of the ASA, AABB, and Society for the Advancement of Patient Blood Management (SABM). -
Timothy Pantoja
Lecturer
BioTimothy Pantoja is the Mellon Fellow of the Humanities at Stanford University and a Lecturer in the Department of African and African American Studies. Prior to coming to Stanford, he was the Medical Humanities Fellow at New York University where he taught courses on the ways the humanities rethinks ideas and practices of healing, recovery, and wholeness. His research explores the ways Black and Caribbean literature and art theorize reflection, doubt, and what it means to participate with the objects that mediate our encounters with each other and a shareable world. His current book project, Scenes of Reflection: Compelling Insinuations, Empathy, and Absorption, analyzes portrayals of reflection in black modernist art and literature alongside the aesthetic evolutions of empathy as a mode of perception. This book reveals how artists such as Henry Tanner, Zora Neale Hurston, Richard Bruce Nugent, and Claude McKay engaged contemporary aesthetic theories on empathy as kinesthesia and synesthesia to show the ways reflection is an act of relation and participation. The aim of this project is to show resonances and connections between these portrayals of reflection during the black modernist period with current aesthetic theories on haptic and synesthetic modes of beholding and reading in Black studies. He also holds a Master of Divinity from Harvard Divinity School which generated writings on the relation between literature and religion. His engagement with religion and art is leading to a second project, entitled, Yet Do I Marvel: Doubt, Curiosity, and Adolescence, which analyzes the ways African American and Caribbean literature, visual art, and film depict doubt as a catalyst for creativity and critique, opening new spaces to (re)consider the fraught intersections between Black religion and artistic expression.
-
Alan C. Pao
Associate Professor of Medicine (Nephrology) and, by courtesy, of Urology
Current Research and Scholarly InterestsWe are broadly interested in how the kidneys control salt, water, and electrolyte homeostasis in the body. Our disease focus is on kidney stone disease. We use cultured kidney cells, transgenic mice, human plasma/urine samples, and electronic health record data to study the pathogenesis of kidney stone disease. Our therapeutic focus is on the development of small molecule compounds that can be used for kidney stone prevention.
